nodes	percent_of_prediction	percent_of_DWPC	metapath
Escitalopram—CHRM1—epilepsy syndrome	0.0973	0.415	CbGaD
Escitalopram—bipolar disorder—Oxcarbazepine—epilepsy syndrome	0.0594	0.162	CpDpCtD
Escitalopram—bipolar disorder—Lamotrigine—epilepsy syndrome	0.0594	0.162	CpDpCtD
Escitalopram—SLC6A4—epilepsy syndrome	0.0517	0.221	CbGaD
Escitalopram—bipolar disorder—Topiramate—epilepsy syndrome	0.0505	0.138	CpDpCtD
Escitalopram—CYP2C19—epilepsy syndrome	0.049	0.209	CbGaD
Escitalopram—endogenous depression—Valproic Acid—epilepsy syndrome	0.0482	0.132	CpDpCtD
Escitalopram—bipolar disorder—Carbamazepine—epilepsy syndrome	0.045	0.123	CpDpCtD
Escitalopram—bipolar disorder—Valproic Acid—epilepsy syndrome	0.0383	0.105	CpDpCtD
Escitalopram—CYP2D6—epilepsy syndrome	0.0363	0.155	CbGaD
Escitalopram—bipolar disorder—Clonazepam—epilepsy syndrome	0.036	0.0984	CpDpCtD
Escitalopram—bipolar disorder—Gabapentin—epilepsy syndrome	0.029	0.0793	CpDpCtD
Escitalopram—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.0132	0.0673	CbGbCtD
Escitalopram—CYP2C19—Trimethadione—epilepsy syndrome	0.0122	0.0626	CbGbCtD
Escitalopram—CYP2C19—Felbamate—epilepsy syndrome	0.0122	0.0626	CbGbCtD
Escitalopram—CYP2C19—Fosphenytoin—epilepsy syndrome	0.0115	0.0589	CbGbCtD
Escitalopram—CYP2C19—Clobazam—epilepsy syndrome	0.00998	0.051	CbGbCtD
Escitalopram—CYP2C19—Carbamazepine—epilepsy syndrome	0.00827	0.0423	CbGbCtD
Escitalopram—CYP2C19—Primidone—epilepsy syndrome	0.00772	0.0395	CbGbCtD
Escitalopram—CYP2C19—Phenytoin—epilepsy syndrome	0.00742	0.0379	CbGbCtD
Escitalopram—CYP2C19—Propofol—epilepsy syndrome	0.00692	0.0354	CbGbCtD
Escitalopram—CYP2C19—Phenobarbital—epilepsy syndrome	0.00661	0.0338	CbGbCtD
Escitalopram—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00637	0.0326	CbGbCtD
Escitalopram—CYP2C19—Diazepam—epilepsy syndrome	0.00627	0.0321	CbGbCtD
Escitalopram—CYP2C19—Zonisamide—epilepsy syndrome	0.00612	0.0313	CbGbCtD
Escitalopram—CYP3A4—Trimethadione—epilepsy syndrome	0.00592	0.0303	CbGbCtD
Escitalopram—CYP3A4—Felbamate—epilepsy syndrome	0.00592	0.0303	CbGbCtD
Escitalopram—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00556	0.0285	CbGbCtD
Escitalopram—CYP2D6—Propofol—epilepsy syndrome	0.00526	0.0269	CbGbCtD
Escitalopram—CYP3A4—Clonazepam—epilepsy syndrome	0.00503	0.0257	CbGbCtD
Escitalopram—CYP2C19—Valproic Acid—epilepsy syndrome	0.00494	0.0253	CbGbCtD
Escitalopram—CYP3A4—Clobazam—epilepsy syndrome	0.00482	0.0247	CbGbCtD
Escitalopram—CYP2C19—Topiramate—epilepsy syndrome	0.00446	0.0228	CbGbCtD
Escitalopram—CYP3A4—Rufinamide—epilepsy syndrome	0.0041	0.021	CbGbCtD
Escitalopram—CYP3A4—Carbamazepine—epilepsy syndrome	0.004	0.0204	CbGbCtD
Escitalopram—CYP3A4—Primidone—epilepsy syndrome	0.00373	0.0191	CbGbCtD
Escitalopram—CYP3A4—Phenytoin—epilepsy syndrome	0.00359	0.0183	CbGbCtD
Escitalopram—CYP3A4—Propofol—epilepsy syndrome	0.00334	0.0171	CbGbCtD
Escitalopram—CYP3A4—Acetazolamide—epilepsy syndrome	0.0032	0.0163	CbGbCtD
Escitalopram—CYP3A4—Phenobarbital—epilepsy syndrome	0.0032	0.0163	CbGbCtD
Escitalopram—CYP3A4—Midazolam—epilepsy syndrome	0.00315	0.0161	CbGbCtD
Escitalopram—CYP3A4—Diazepam—epilepsy syndrome	0.00303	0.0155	CbGbCtD
Escitalopram—CYP3A4—Zonisamide—epilepsy syndrome	0.00296	0.0151	CbGbCtD
Escitalopram—CYP3A4—Valproic Acid—epilepsy syndrome	0.00239	0.0122	CbGbCtD
Escitalopram—SLC6A2—locus ceruleus—epilepsy syndrome	0.00224	0.0945	CbGeAlD
Escitalopram—CYP3A4—Topiramate—epilepsy syndrome	0.00215	0.011	CbGbCtD
Escitalopram—SLC6A3—telencephalic ventricle—epilepsy syndrome	0.00132	0.0555	CbGeAlD
Escitalopram—HTR2C—telencephalic ventricle—epilepsy syndrome	0.00127	0.0537	CbGeAlD
Escitalopram—SLC6A2—autonomic nervous system—epilepsy syndrome	0.00119	0.0502	CbGeAlD
Escitalopram—SLC6A3—ganglion—epilepsy syndrome	0.00082	0.0346	CbGeAlD
Escitalopram—HTR2C—ganglion—epilepsy syndrome	0.000793	0.0334	CbGeAlD
Escitalopram—Citalopram—CHRM1—epilepsy syndrome	0.000779	0.374	CrCbGaD
Escitalopram—SLC6A4—ganglion—epilepsy syndrome	0.000752	0.0317	CbGeAlD
Escitalopram—SLC6A2—ganglion—epilepsy syndrome	0.000662	0.0279	CbGeAlD
Escitalopram—SLC6A3—hindbrain—epilepsy syndrome	0.000622	0.0262	CbGeAlD
Escitalopram—SLC6A4—hindbrain—epilepsy syndrome	0.00057	0.024	CbGeAlD
Escitalopram—ADRA1A—hindbrain—epilepsy syndrome	0.000467	0.0197	CbGeAlD
Escitalopram—Citalopram—SLC6A4—epilepsy syndrome	0.000414	0.199	CrCbGaD
Escitalopram—Citalopram—CYP2C19—epilepsy syndrome	0.000392	0.188	CrCbGaD
Escitalopram—SLC6A3—brainstem—epilepsy syndrome	0.000357	0.015	CbGeAlD
Escitalopram—HTR2C—brainstem—epilepsy syndrome	0.000345	0.0145	CbGeAlD
Escitalopram—SLC6A3—forebrain—epilepsy syndrome	0.000344	0.0145	CbGeAlD
Escitalopram—HTR2C—forebrain—epilepsy syndrome	0.000333	0.014	CbGeAlD
Escitalopram—SLC6A4—brainstem—epilepsy syndrome	0.000327	0.0138	CbGeAlD
Escitalopram—SLC6A3—telencephalon—epilepsy syndrome	0.000317	0.0133	CbGeAlD
Escitalopram—SLC6A4—forebrain—epilepsy syndrome	0.000315	0.0133	CbGeAlD
Escitalopram—CHRM1—forebrain—epilepsy syndrome	0.000314	0.0132	CbGeAlD
Escitalopram—HTR2C—telencephalon—epilepsy syndrome	0.000306	0.0129	CbGeAlD
Escitalopram—Citalopram—CYP2D6—epilepsy syndrome	0.000291	0.14	CrCbGaD
Escitalopram—SLC6A4—telencephalon—epilepsy syndrome	0.00029	0.0122	CbGeAlD
Escitalopram—CHRM1—telencephalon—epilepsy syndrome	0.000289	0.0122	CbGeAlD
Escitalopram—SLC6A2—brainstem—epilepsy syndrome	0.000288	0.0121	CbGeAlD
Escitalopram—SLC6A2—forebrain—epilepsy syndrome	0.000278	0.0117	CbGeAlD
Escitalopram—CYP2D6—hindbrain—epilepsy syndrome	0.000275	0.0116	CbGeAlD
Escitalopram—ADRA1A—brainstem—epilepsy syndrome	0.000267	0.0113	CbGeAlD
Escitalopram—ADRA1A—forebrain—epilepsy syndrome	0.000258	0.0109	CbGeAlD
Escitalopram—SLC6A2—telencephalon—epilepsy syndrome	0.000255	0.0108	CbGeAlD
Escitalopram—HTR2C—medulla oblongata—epilepsy syndrome	0.00024	0.0101	CbGeAlD
Escitalopram—ADRA1A—telencephalon—epilepsy syndrome	0.000237	0.01	CbGeAlD
Escitalopram—SLC6A3—midbrain—epilepsy syndrome	0.000227	0.00958	CbGeAlD
Escitalopram—SLC6A3—spinal cord—epilepsy syndrome	0.000222	0.00934	CbGeAlD
Escitalopram—HTR2C—midbrain—epilepsy syndrome	0.00022	0.00926	CbGeAlD
Escitalopram—HTR2C—spinal cord—epilepsy syndrome	0.000214	0.00903	CbGeAlD
Escitalopram—SLC6A4—midbrain—epilepsy syndrome	0.000208	0.00878	CbGeAlD
Escitalopram—Citalopram—ABCB1—epilepsy syndrome	0.000208	0.0997	CrCbGaD
Escitalopram—SLC6A4—spinal cord—epilepsy syndrome	0.000203	0.00856	CbGeAlD
Escitalopram—SLC6A2—medulla oblongata—epilepsy syndrome	0.000201	0.00845	CbGeAlD
Escitalopram—HRH1—forebrain—epilepsy syndrome	0.0002	0.00842	CbGeAlD
Escitalopram—SLC6A3—head—epilepsy syndrome	0.000197	0.0083	CbGeAlD
Escitalopram—HTR2C—head—epilepsy syndrome	0.000191	0.00803	CbGeAlD
Escitalopram—SLC6A3—nervous system—epilepsy syndrome	0.000187	0.00787	CbGeAlD
Escitalopram—HRH1—telencephalon—epilepsy syndrome	0.000184	0.00774	CbGeAlD
Escitalopram—HTR2C—nervous system—epilepsy syndrome	0.000181	0.00761	CbGeAlD
Escitalopram—SLC6A4—head—epilepsy syndrome	0.000181	0.00761	CbGeAlD
Escitalopram—CHRM1—head—epilepsy syndrome	0.00018	0.00758	CbGeAlD
Escitalopram—SLC6A3—central nervous system—epilepsy syndrome	0.00018	0.00758	CbGeAlD
Escitalopram—SLC6A3—cerebellum—epilepsy syndrome	0.000176	0.00741	CbGeAlD
Escitalopram—HTR2C—central nervous system—epilepsy syndrome	0.000174	0.00733	CbGeAlD
Escitalopram—SLC6A4—nervous system—epilepsy syndrome	0.000171	0.00721	CbGeAlD
Escitalopram—CHRM1—nervous system—epilepsy syndrome	0.000171	0.00719	CbGeAlD
Escitalopram—SLC6A4—central nervous system—epilepsy syndrome	0.000165	0.00695	CbGeAlD
Escitalopram—CHRM1—central nervous system—epilepsy syndrome	0.000164	0.00692	CbGeAlD
Escitalopram—SLC6A2—head—epilepsy syndrome	0.000159	0.0067	CbGeAlD
Escitalopram—CYP2D6—brainstem—epilepsy syndrome	0.000158	0.00664	CbGeAlD
Escitalopram—CYP2D6—forebrain—epilepsy syndrome	0.000152	0.00641	CbGeAlD
Escitalopram—SLC6A2—nervous system—epilepsy syndrome	0.000151	0.00635	CbGeAlD
Escitalopram—ADRA1A—head—epilepsy syndrome	0.000148	0.00623	CbGeAlD
Escitalopram—SLC6A2—central nervous system—epilepsy syndrome	0.000145	0.00612	CbGeAlD
Escitalopram—SLC6A3—brain—epilepsy syndrome	0.000143	0.00602	CbGeAlD
Escitalopram—ADRA1A—nervous system—epilepsy syndrome	0.00014	0.00591	CbGeAlD
Escitalopram—CYP2D6—telencephalon—epilepsy syndrome	0.00014	0.00589	CbGeAlD
Escitalopram—HTR2C—brain—epilepsy syndrome	0.000138	0.00582	CbGeAlD
Escitalopram—ADRA1A—central nervous system—epilepsy syndrome	0.000135	0.00569	CbGeAlD
Escitalopram—ADRA1A—cerebellum—epilepsy syndrome	0.000132	0.00556	CbGeAlD
Escitalopram—SLC6A4—brain—epilepsy syndrome	0.000131	0.00551	CbGeAlD
Escitalopram—CHRM1—brain—epilepsy syndrome	0.00013	0.00549	CbGeAlD
Escitalopram—SLC6A2—brain—epilepsy syndrome	0.000115	0.00486	CbGeAlD
Escitalopram—HRH1—head—epilepsy syndrome	0.000114	0.00482	CbGeAlD
Escitalopram—HRH1—nervous system—epilepsy syndrome	0.000108	0.00457	CbGeAlD
Escitalopram—ADRA1A—brain—epilepsy syndrome	0.000107	0.00451	CbGeAlD
Escitalopram—HRH1—central nervous system—epilepsy syndrome	0.000104	0.0044	CbGeAlD
Escitalopram—CYP2D6—head—epilepsy syndrome	8.71e-05	0.00367	CbGeAlD
Escitalopram—CYP3A4—nervous system—epilepsy syndrome	8.39e-05	0.00353	CbGeAlD
Escitalopram—HRH1—brain—epilepsy syndrome	8.29e-05	0.00349	CbGeAlD
Escitalopram—CYP2D6—nervous system—epilepsy syndrome	8.25e-05	0.00348	CbGeAlD
Escitalopram—CYP3A4—central nervous system—epilepsy syndrome	8.08e-05	0.0034	CbGeAlD
Escitalopram—CYP2D6—central nervous system—epilepsy syndrome	7.95e-05	0.00335	CbGeAlD
Escitalopram—CYP2D6—cerebellum—epilepsy syndrome	7.77e-05	0.00327	CbGeAlD
Escitalopram—CYP2D6—brain—epilepsy syndrome	6.31e-05	0.00266	CbGeAlD
Escitalopram—Asthenia—Carbamazepine—epilepsy syndrome	8.06e-06	5.95e-05	CcSEcCtD
Escitalopram—Agitation—Gabapentin—epilepsy syndrome	8.05e-06	5.94e-05	CcSEcCtD
Escitalopram—Diarrhoea—Phenytoin—epilepsy syndrome	8.05e-06	5.94e-05	CcSEcCtD
Escitalopram—Discomfort—Pregabalin—epilepsy syndrome	8.04e-06	5.93e-05	CcSEcCtD
Escitalopram—Nausea—Fosphenytoin—epilepsy syndrome	8.03e-06	5.93e-05	CcSEcCtD
Escitalopram—Diarrhoea—Oxcarbazepine—epilepsy syndrome	8.01e-06	5.91e-05	CcSEcCtD
Escitalopram—Erythema multiforme—Topiramate—epilepsy syndrome	8.01e-06	5.91e-05	CcSEcCtD
Escitalopram—Angioedema—Gabapentin—epilepsy syndrome	8.01e-06	5.91e-05	CcSEcCtD
Escitalopram—Hypersensitivity—Lamotrigine—epilepsy syndrome	8e-06	5.9e-05	CcSEcCtD
Escitalopram—Vomiting—Felbamate—epilepsy syndrome	7.98e-06	5.89e-05	CcSEcCtD
Escitalopram—Dry mouth—Pregabalin—epilepsy syndrome	7.95e-06	5.87e-05	CcSEcCtD
Escitalopram—Pruritus—Carbamazepine—epilepsy syndrome	7.95e-06	5.86e-05	CcSEcCtD
Escitalopram—Rash—Felbamate—epilepsy syndrome	7.92e-06	5.84e-05	CcSEcCtD
Escitalopram—Eye disorder—Topiramate—epilepsy syndrome	7.91e-06	5.84e-05	CcSEcCtD
Escitalopram—Dermatitis—Felbamate—epilepsy syndrome	7.91e-06	5.84e-05	CcSEcCtD
Escitalopram—Malaise—Gabapentin—epilepsy syndrome	7.9e-06	5.83e-05	CcSEcCtD
Escitalopram—Tinnitus—Topiramate—epilepsy syndrome	7.89e-06	5.83e-05	CcSEcCtD
Escitalopram—Vertigo—Gabapentin—epilepsy syndrome	7.87e-06	5.81e-05	CcSEcCtD
Escitalopram—Headache—Felbamate—epilepsy syndrome	7.87e-06	5.8e-05	CcSEcCtD
Escitalopram—Confusional state—Pregabalin—epilepsy syndrome	7.86e-06	5.8e-05	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	7.86e-06	5.8e-05	CcSEcCtD
Escitalopram—Cardiac disorder—Topiramate—epilepsy syndrome	7.86e-06	5.8e-05	CcSEcCtD
Escitalopram—Flushing—Topiramate—epilepsy syndrome	7.86e-06	5.8e-05	CcSEcCtD
Escitalopram—Syncope—Gabapentin—epilepsy syndrome	7.86e-06	5.8e-05	CcSEcCtD
Escitalopram—Leukopenia—Gabapentin—epilepsy syndrome	7.84e-06	5.79e-05	CcSEcCtD
Escitalopram—Dizziness—Clonazepam—epilepsy syndrome	7.83e-06	5.78e-05	CcSEcCtD
Escitalopram—Nausea—Vigabatrin—epilepsy syndrome	7.83e-06	5.78e-05	CcSEcCtD
Escitalopram—Vomiting—Zonisamide—epilepsy syndrome	7.81e-06	5.77e-05	CcSEcCtD
Escitalopram—Insomnia—Valproic Acid—epilepsy syndrome	7.8e-06	5.76e-05	CcSEcCtD
Escitalopram—Anaphylactic shock—Pregabalin—epilepsy syndrome	7.8e-06	5.75e-05	CcSEcCtD
Escitalopram—Oedema—Pregabalin—epilepsy syndrome	7.8e-06	5.75e-05	CcSEcCtD
Escitalopram—Asthenia—Lamotrigine—epilepsy syndrome	7.79e-06	5.75e-05	CcSEcCtD
Escitalopram—Dizziness—Phenytoin—epilepsy syndrome	7.78e-06	5.74e-05	CcSEcCtD
Escitalopram—Rash—Zonisamide—epilepsy syndrome	7.75e-06	5.72e-05	CcSEcCtD
Escitalopram—Infection—Pregabalin—epilepsy syndrome	7.75e-06	5.72e-05	CcSEcCtD
Escitalopram—Paraesthesia—Valproic Acid—epilepsy syndrome	7.74e-06	5.71e-05	CcSEcCtD
Escitalopram—Palpitations—Gabapentin—epilepsy syndrome	7.74e-06	5.71e-05	CcSEcCtD
Escitalopram—Dermatitis—Zonisamide—epilepsy syndrome	7.74e-06	5.71e-05	CcSEcCtD
Escitalopram—Dizziness—Oxcarbazepine—epilepsy syndrome	7.74e-06	5.71e-05	CcSEcCtD
Escitalopram—Nausea—Diazepam—epilepsy syndrome	7.71e-06	5.69e-05	CcSEcCtD
Escitalopram—Loss of consciousness—Gabapentin—epilepsy syndrome	7.7e-06	5.68e-05	CcSEcCtD
Escitalopram—Headache—Zonisamide—epilepsy syndrome	7.7e-06	5.68e-05	CcSEcCtD
Escitalopram—Dyspnoea—Valproic Acid—epilepsy syndrome	7.69e-06	5.67e-05	CcSEcCtD
Escitalopram—Diarrhoea—Carbamazepine—epilepsy syndrome	7.68e-06	5.67e-05	CcSEcCtD
Escitalopram—Angiopathy—Topiramate—epilepsy syndrome	7.68e-06	5.67e-05	CcSEcCtD
Escitalopram—Pruritus—Lamotrigine—epilepsy syndrome	7.68e-06	5.67e-05	CcSEcCtD
Escitalopram—Shock—Pregabalin—epilepsy syndrome	7.67e-06	5.66e-05	CcSEcCtD
Escitalopram—Somnolence—Valproic Acid—epilepsy syndrome	7.67e-06	5.66e-05	CcSEcCtD
Escitalopram—Immune system disorder—Topiramate—epilepsy syndrome	7.65e-06	5.64e-05	CcSEcCtD
Escitalopram—Nervous system disorder—Pregabalin—epilepsy syndrome	7.65e-06	5.64e-05	CcSEcCtD
Escitalopram—Cough—Gabapentin—epilepsy syndrome	7.64e-06	5.64e-05	CcSEcCtD
Escitalopram—Thrombocytopenia—Pregabalin—epilepsy syndrome	7.63e-06	5.63e-05	CcSEcCtD
Escitalopram—Mediastinal disorder—Topiramate—epilepsy syndrome	7.63e-06	5.63e-05	CcSEcCtD
Escitalopram—Tachycardia—Pregabalin—epilepsy syndrome	7.61e-06	5.62e-05	CcSEcCtD
Escitalopram—Chills—Topiramate—epilepsy syndrome	7.6e-06	5.61e-05	CcSEcCtD
Escitalopram—Dyspepsia—Valproic Acid—epilepsy syndrome	7.59e-06	5.6e-05	CcSEcCtD
Escitalopram—Convulsion—Gabapentin—epilepsy syndrome	7.59e-06	5.6e-05	CcSEcCtD
Escitalopram—Skin disorder—Pregabalin—epilepsy syndrome	7.57e-06	5.59e-05	CcSEcCtD
Escitalopram—Hypertension—Gabapentin—epilepsy syndrome	7.56e-06	5.58e-05	CcSEcCtD
Escitalopram—Hyperhidrosis—Pregabalin—epilepsy syndrome	7.54e-06	5.56e-05	CcSEcCtD
Escitalopram—Vomiting—Clonazepam—epilepsy syndrome	7.53e-06	5.56e-05	CcSEcCtD
Escitalopram—Decreased appetite—Valproic Acid—epilepsy syndrome	7.5e-06	5.53e-05	CcSEcCtD
Escitalopram—Alopecia—Topiramate—epilepsy syndrome	7.48e-06	5.52e-05	CcSEcCtD
Escitalopram—Vomiting—Phenytoin—epilepsy syndrome	7.48e-06	5.52e-05	CcSEcCtD
Escitalopram—Rash—Clonazepam—epilepsy syndrome	7.47e-06	5.51e-05	CcSEcCtD
Escitalopram—Dermatitis—Clonazepam—epilepsy syndrome	7.46e-06	5.51e-05	CcSEcCtD
Escitalopram—Arthralgia—Gabapentin—epilepsy syndrome	7.46e-06	5.5e-05	CcSEcCtD
Escitalopram—Myalgia—Gabapentin—epilepsy syndrome	7.46e-06	5.5e-05	CcSEcCtD
Escitalopram—Chest pain—Gabapentin—epilepsy syndrome	7.46e-06	5.5e-05	CcSEcCtD
Escitalopram—Nausea—Felbamate—epilepsy syndrome	7.46e-06	5.5e-05	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	7.45e-06	5.49e-05	CcSEcCtD
Escitalopram—Vomiting—Oxcarbazepine—epilepsy syndrome	7.44e-06	5.49e-05	CcSEcCtD
Escitalopram—Fatigue—Valproic Acid—epilepsy syndrome	7.44e-06	5.49e-05	CcSEcCtD
Escitalopram—Anxiety—Gabapentin—epilepsy syndrome	7.43e-06	5.48e-05	CcSEcCtD
Escitalopram—Anorexia—Pregabalin—epilepsy syndrome	7.43e-06	5.48e-05	CcSEcCtD
Escitalopram—Dizziness—Carbamazepine—epilepsy syndrome	7.43e-06	5.48e-05	CcSEcCtD
Escitalopram—Diarrhoea—Lamotrigine—epilepsy syndrome	7.43e-06	5.48e-05	CcSEcCtD
Escitalopram—Headache—Clonazepam—epilepsy syndrome	7.42e-06	5.48e-05	CcSEcCtD
Escitalopram—Rash—Phenytoin—epilepsy syndrome	7.42e-06	5.47e-05	CcSEcCtD
Escitalopram—Mental disorder—Topiramate—epilepsy syndrome	7.42e-06	5.47e-05	CcSEcCtD
Escitalopram—Dermatitis—Phenytoin—epilepsy syndrome	7.41e-06	5.47e-05	CcSEcCtD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	7.41e-06	5.47e-05	CcSEcCtD
Escitalopram—Rash—Oxcarbazepine—epilepsy syndrome	7.38e-06	5.45e-05	CcSEcCtD
Escitalopram—Constipation—Valproic Acid—epilepsy syndrome	7.38e-06	5.44e-05	CcSEcCtD
Escitalopram—Pain—Valproic Acid—epilepsy syndrome	7.38e-06	5.44e-05	CcSEcCtD
Escitalopram—Dermatitis—Oxcarbazepine—epilepsy syndrome	7.37e-06	5.44e-05	CcSEcCtD
Escitalopram—Headache—Phenytoin—epilepsy syndrome	7.37e-06	5.44e-05	CcSEcCtD
Escitalopram—Malnutrition—Topiramate—epilepsy syndrome	7.37e-06	5.44e-05	CcSEcCtD
Escitalopram—Erythema—Topiramate—epilepsy syndrome	7.37e-06	5.44e-05	CcSEcCtD
Escitalopram—Discomfort—Gabapentin—epilepsy syndrome	7.37e-06	5.44e-05	CcSEcCtD
Escitalopram—Headache—Oxcarbazepine—epilepsy syndrome	7.33e-06	5.41e-05	CcSEcCtD
Escitalopram—Nausea—Zonisamide—epilepsy syndrome	7.3e-06	5.39e-05	CcSEcCtD
Escitalopram—Dry mouth—Gabapentin—epilepsy syndrome	7.29e-06	5.38e-05	CcSEcCtD
Escitalopram—Hypotension—Pregabalin—epilepsy syndrome	7.29e-06	5.38e-05	CcSEcCtD
Escitalopram—Flatulence—Topiramate—epilepsy syndrome	7.26e-06	5.36e-05	CcSEcCtD
Escitalopram—Tension—Topiramate—epilepsy syndrome	7.23e-06	5.34e-05	CcSEcCtD
Escitalopram—Dysgeusia—Topiramate—epilepsy syndrome	7.22e-06	5.33e-05	CcSEcCtD
Escitalopram—Confusional state—Gabapentin—epilepsy syndrome	7.21e-06	5.32e-05	CcSEcCtD
Escitalopram—Dizziness—Lamotrigine—epilepsy syndrome	7.18e-06	5.3e-05	CcSEcCtD
Escitalopram—Nervousness—Topiramate—epilepsy syndrome	7.16e-06	5.28e-05	CcSEcCtD
Escitalopram—Oedema—Gabapentin—epilepsy syndrome	7.15e-06	5.28e-05	CcSEcCtD
Escitalopram—Anaphylactic shock—Gabapentin—epilepsy syndrome	7.15e-06	5.28e-05	CcSEcCtD
Escitalopram—Vomiting—Carbamazepine—epilepsy syndrome	7.14e-06	5.27e-05	CcSEcCtD
Escitalopram—Back pain—Topiramate—epilepsy syndrome	7.13e-06	5.26e-05	CcSEcCtD
Escitalopram—Feeling abnormal—Valproic Acid—epilepsy syndrome	7.11e-06	5.24e-05	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	7.1e-06	5.24e-05	CcSEcCtD
Escitalopram—Infection—Gabapentin—epilepsy syndrome	7.1e-06	5.24e-05	CcSEcCtD
Escitalopram—Muscle spasms—Topiramate—epilepsy syndrome	7.09e-06	5.23e-05	CcSEcCtD
Escitalopram—Rash—Carbamazepine—epilepsy syndrome	7.08e-06	5.23e-05	CcSEcCtD
Escitalopram—Dermatitis—Carbamazepine—epilepsy syndrome	7.07e-06	5.22e-05	CcSEcCtD
Escitalopram—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	7.05e-06	5.2e-05	CcSEcCtD
Escitalopram—Insomnia—Pregabalin—epilepsy syndrome	7.05e-06	5.2e-05	CcSEcCtD
Escitalopram—Nausea—Clonazepam—epilepsy syndrome	7.04e-06	5.19e-05	CcSEcCtD
Escitalopram—Headache—Carbamazepine—epilepsy syndrome	7.04e-06	5.19e-05	CcSEcCtD
Escitalopram—Shock—Gabapentin—epilepsy syndrome	7.03e-06	5.19e-05	CcSEcCtD
Escitalopram—Nervous system disorder—Gabapentin—epilepsy syndrome	7.01e-06	5.17e-05	CcSEcCtD
Escitalopram—Paraesthesia—Pregabalin—epilepsy syndrome	7e-06	5.17e-05	CcSEcCtD
Escitalopram—Thrombocytopenia—Gabapentin—epilepsy syndrome	7e-06	5.17e-05	CcSEcCtD
Escitalopram—Nausea—Phenytoin—epilepsy syndrome	6.99e-06	5.16e-05	CcSEcCtD
Escitalopram—Tachycardia—Gabapentin—epilepsy syndrome	6.98e-06	5.15e-05	CcSEcCtD
Escitalopram—Dyspnoea—Pregabalin—epilepsy syndrome	6.95e-06	5.13e-05	CcSEcCtD
Escitalopram—Nausea—Oxcarbazepine—epilepsy syndrome	6.95e-06	5.13e-05	CcSEcCtD
Escitalopram—Vision blurred—Topiramate—epilepsy syndrome	6.95e-06	5.13e-05	CcSEcCtD
Escitalopram—Skin disorder—Gabapentin—epilepsy syndrome	6.94e-06	5.12e-05	CcSEcCtD
Escitalopram—Somnolence—Pregabalin—epilepsy syndrome	6.93e-06	5.12e-05	CcSEcCtD
Escitalopram—Hyperhidrosis—Gabapentin—epilepsy syndrome	6.91e-06	5.1e-05	CcSEcCtD
Escitalopram—Tremor—Topiramate—epilepsy syndrome	6.91e-06	5.1e-05	CcSEcCtD
Escitalopram—Vomiting—Lamotrigine—epilepsy syndrome	6.9e-06	5.09e-05	CcSEcCtD
Escitalopram—Urticaria—Valproic Acid—epilepsy syndrome	6.85e-06	5.06e-05	CcSEcCtD
Escitalopram—Rash—Lamotrigine—epilepsy syndrome	6.84e-06	5.05e-05	CcSEcCtD
Escitalopram—Ill-defined disorder—Topiramate—epilepsy syndrome	6.84e-06	5.05e-05	CcSEcCtD
Escitalopram—Dermatitis—Lamotrigine—epilepsy syndrome	6.84e-06	5.05e-05	CcSEcCtD
Escitalopram—Body temperature increased—Valproic Acid—epilepsy syndrome	6.82e-06	5.03e-05	CcSEcCtD
Escitalopram—Abdominal pain—Valproic Acid—epilepsy syndrome	6.82e-06	5.03e-05	CcSEcCtD
Escitalopram—Anorexia—Gabapentin—epilepsy syndrome	6.82e-06	5.03e-05	CcSEcCtD
Escitalopram—Anaemia—Topiramate—epilepsy syndrome	6.81e-06	5.03e-05	CcSEcCtD
Escitalopram—Headache—Lamotrigine—epilepsy syndrome	6.8e-06	5.02e-05	CcSEcCtD
Escitalopram—Decreased appetite—Pregabalin—epilepsy syndrome	6.78e-06	5e-05	CcSEcCtD
Escitalopram—Agitation—Topiramate—epilepsy syndrome	6.77e-06	5e-05	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	6.73e-06	4.97e-05	CcSEcCtD
Escitalopram—Fatigue—Pregabalin—epilepsy syndrome	6.72e-06	4.96e-05	CcSEcCtD
Escitalopram—Hypotension—Gabapentin—epilepsy syndrome	6.68e-06	4.93e-05	CcSEcCtD
Escitalopram—Nausea—Carbamazepine—epilepsy syndrome	6.67e-06	4.92e-05	CcSEcCtD
Escitalopram—Pain—Pregabalin—epilepsy syndrome	6.67e-06	4.92e-05	CcSEcCtD
Escitalopram—Constipation—Pregabalin—epilepsy syndrome	6.67e-06	4.92e-05	CcSEcCtD
Escitalopram—Malaise—Topiramate—epilepsy syndrome	6.65e-06	4.9e-05	CcSEcCtD
Escitalopram—Vertigo—Topiramate—epilepsy syndrome	6.62e-06	4.89e-05	CcSEcCtD
Escitalopram—Syncope—Topiramate—epilepsy syndrome	6.61e-06	4.88e-05	CcSEcCtD
Escitalopram—Leukopenia—Topiramate—epilepsy syndrome	6.6e-06	4.87e-05	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	6.51e-06	4.81e-05	CcSEcCtD
Escitalopram—Palpitations—Topiramate—epilepsy syndrome	6.51e-06	4.81e-05	CcSEcCtD
Escitalopram—Loss of consciousness—Topiramate—epilepsy syndrome	6.48e-06	4.78e-05	CcSEcCtD
Escitalopram—Insomnia—Gabapentin—epilepsy syndrome	6.47e-06	4.77e-05	CcSEcCtD
Escitalopram—Nausea—Lamotrigine—epilepsy syndrome	6.45e-06	4.76e-05	CcSEcCtD
Escitalopram—Cough—Topiramate—epilepsy syndrome	6.43e-06	4.75e-05	CcSEcCtD
Escitalopram—Feeling abnormal—Pregabalin—epilepsy syndrome	6.43e-06	4.74e-05	CcSEcCtD
Escitalopram—Paraesthesia—Gabapentin—epilepsy syndrome	6.42e-06	4.74e-05	CcSEcCtD
Escitalopram—Convulsion—Topiramate—epilepsy syndrome	6.39e-06	4.71e-05	CcSEcCtD
Escitalopram—Gastrointestinal pain—Pregabalin—epilepsy syndrome	6.38e-06	4.7e-05	CcSEcCtD
Escitalopram—Dyspnoea—Gabapentin—epilepsy syndrome	6.37e-06	4.7e-05	CcSEcCtD
Escitalopram—Hypertension—Topiramate—epilepsy syndrome	6.36e-06	4.7e-05	CcSEcCtD
Escitalopram—Somnolence—Gabapentin—epilepsy syndrome	6.36e-06	4.69e-05	CcSEcCtD
Escitalopram—Hypersensitivity—Valproic Acid—epilepsy syndrome	6.35e-06	4.69e-05	CcSEcCtD
Escitalopram—Dyspepsia—Gabapentin—epilepsy syndrome	6.29e-06	4.64e-05	CcSEcCtD
Escitalopram—Chest pain—Topiramate—epilepsy syndrome	6.27e-06	4.63e-05	CcSEcCtD
Escitalopram—Myalgia—Topiramate—epilepsy syndrome	6.27e-06	4.63e-05	CcSEcCtD
Escitalopram—Arthralgia—Topiramate—epilepsy syndrome	6.27e-06	4.63e-05	CcSEcCtD
Escitalopram—Anxiety—Topiramate—epilepsy syndrome	6.25e-06	4.61e-05	CcSEcCtD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	6.23e-06	4.6e-05	CcSEcCtD
Escitalopram—Decreased appetite—Gabapentin—epilepsy syndrome	6.22e-06	4.59e-05	CcSEcCtD
Escitalopram—Discomfort—Topiramate—epilepsy syndrome	6.2e-06	4.57e-05	CcSEcCtD
Escitalopram—Urticaria—Pregabalin—epilepsy syndrome	6.19e-06	4.57e-05	CcSEcCtD
Escitalopram—Asthenia—Valproic Acid—epilepsy syndrome	6.19e-06	4.57e-05	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	6.17e-06	4.55e-05	CcSEcCtD
Escitalopram—Fatigue—Gabapentin—epilepsy syndrome	6.16e-06	4.55e-05	CcSEcCtD
Escitalopram—Abdominal pain—Pregabalin—epilepsy syndrome	6.16e-06	4.55e-05	CcSEcCtD
Escitalopram—Body temperature increased—Pregabalin—epilepsy syndrome	6.16e-06	4.55e-05	CcSEcCtD
Escitalopram—Dry mouth—Topiramate—epilepsy syndrome	6.14e-06	4.53e-05	CcSEcCtD
Escitalopram—Pain—Gabapentin—epilepsy syndrome	6.11e-06	4.51e-05	CcSEcCtD
Escitalopram—Constipation—Gabapentin—epilepsy syndrome	6.11e-06	4.51e-05	CcSEcCtD
Escitalopram—Pruritus—Valproic Acid—epilepsy syndrome	6.1e-06	4.5e-05	CcSEcCtD
Escitalopram—Confusional state—Topiramate—epilepsy syndrome	6.07e-06	4.48e-05	CcSEcCtD
Escitalopram—Oedema—Topiramate—epilepsy syndrome	6.02e-06	4.44e-05	CcSEcCtD
Escitalopram—Infection—Topiramate—epilepsy syndrome	5.98e-06	4.41e-05	CcSEcCtD
Escitalopram—Shock—Topiramate—epilepsy syndrome	5.92e-06	4.37e-05	CcSEcCtD
Escitalopram—Diarrhoea—Valproic Acid—epilepsy syndrome	5.9e-06	4.35e-05	CcSEcCtD
Escitalopram—Nervous system disorder—Topiramate—epilepsy syndrome	5.9e-06	4.35e-05	CcSEcCtD
Escitalopram—Feeling abnormal—Gabapentin—epilepsy syndrome	5.89e-06	4.35e-05	CcSEcCtD
Escitalopram—Thrombocytopenia—Topiramate—epilepsy syndrome	5.89e-06	4.35e-05	CcSEcCtD
Escitalopram—Tachycardia—Topiramate—epilepsy syndrome	5.87e-06	4.33e-05	CcSEcCtD
Escitalopram—Gastrointestinal pain—Gabapentin—epilepsy syndrome	5.85e-06	4.31e-05	CcSEcCtD
Escitalopram—Skin disorder—Topiramate—epilepsy syndrome	5.84e-06	4.31e-05	CcSEcCtD
Escitalopram—Hyperhidrosis—Topiramate—epilepsy syndrome	5.82e-06	4.29e-05	CcSEcCtD
Escitalopram—Hypersensitivity—Pregabalin—epilepsy syndrome	5.74e-06	4.24e-05	CcSEcCtD
Escitalopram—Anorexia—Topiramate—epilepsy syndrome	5.73e-06	4.23e-05	CcSEcCtD
Escitalopram—Dizziness—Valproic Acid—epilepsy syndrome	5.7e-06	4.21e-05	CcSEcCtD
Escitalopram—Urticaria—Gabapentin—epilepsy syndrome	5.68e-06	4.19e-05	CcSEcCtD
Escitalopram—Abdominal pain—Gabapentin—epilepsy syndrome	5.65e-06	4.17e-05	CcSEcCtD
Escitalopram—Body temperature increased—Gabapentin—epilepsy syndrome	5.65e-06	4.17e-05	CcSEcCtD
Escitalopram—Hypotension—Topiramate—epilepsy syndrome	5.62e-06	4.15e-05	CcSEcCtD
Escitalopram—Asthenia—Pregabalin—epilepsy syndrome	5.59e-06	4.13e-05	CcSEcCtD
Escitalopram—Pruritus—Pregabalin—epilepsy syndrome	5.52e-06	4.07e-05	CcSEcCtD
Escitalopram—Vomiting—Valproic Acid—epilepsy syndrome	5.48e-06	4.05e-05	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	5.48e-06	4.04e-05	CcSEcCtD
Escitalopram—Insomnia—Topiramate—epilepsy syndrome	5.44e-06	4.01e-05	CcSEcCtD
Escitalopram—Rash—Valproic Acid—epilepsy syndrome	5.44e-06	4.01e-05	CcSEcCtD
Escitalopram—Dermatitis—Valproic Acid—epilepsy syndrome	5.43e-06	4.01e-05	CcSEcCtD
Escitalopram—Headache—Valproic Acid—epilepsy syndrome	5.4e-06	3.99e-05	CcSEcCtD
Escitalopram—Paraesthesia—Topiramate—epilepsy syndrome	5.4e-06	3.99e-05	CcSEcCtD
Escitalopram—Dyspnoea—Topiramate—epilepsy syndrome	5.36e-06	3.96e-05	CcSEcCtD
Escitalopram—Somnolence—Topiramate—epilepsy syndrome	5.35e-06	3.95e-05	CcSEcCtD
Escitalopram—Diarrhoea—Pregabalin—epilepsy syndrome	5.34e-06	3.94e-05	CcSEcCtD
Escitalopram—Dyspepsia—Topiramate—epilepsy syndrome	5.3e-06	3.91e-05	CcSEcCtD
Escitalopram—Hypersensitivity—Gabapentin—epilepsy syndrome	5.27e-06	3.89e-05	CcSEcCtD
Escitalopram—Decreased appetite—Topiramate—epilepsy syndrome	5.23e-06	3.86e-05	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Topiramate—epilepsy syndrome	5.19e-06	3.83e-05	CcSEcCtD
Escitalopram—Fatigue—Topiramate—epilepsy syndrome	5.19e-06	3.83e-05	CcSEcCtD
Escitalopram—Dizziness—Pregabalin—epilepsy syndrome	5.16e-06	3.8e-05	CcSEcCtD
Escitalopram—Pain—Topiramate—epilepsy syndrome	5.14e-06	3.8e-05	CcSEcCtD
Escitalopram—Constipation—Topiramate—epilepsy syndrome	5.14e-06	3.8e-05	CcSEcCtD
Escitalopram—Asthenia—Gabapentin—epilepsy syndrome	5.13e-06	3.79e-05	CcSEcCtD
Escitalopram—Nausea—Valproic Acid—epilepsy syndrome	5.12e-06	3.78e-05	CcSEcCtD
Escitalopram—Pruritus—Gabapentin—epilepsy syndrome	5.06e-06	3.73e-05	CcSEcCtD
Escitalopram—Vomiting—Pregabalin—epilepsy syndrome	4.96e-06	3.66e-05	CcSEcCtD
Escitalopram—Feeling abnormal—Topiramate—epilepsy syndrome	4.96e-06	3.66e-05	CcSEcCtD
Escitalopram—Gastrointestinal pain—Topiramate—epilepsy syndrome	4.92e-06	3.63e-05	CcSEcCtD
Escitalopram—Rash—Pregabalin—epilepsy syndrome	4.92e-06	3.63e-05	CcSEcCtD
Escitalopram—Dermatitis—Pregabalin—epilepsy syndrome	4.91e-06	3.62e-05	CcSEcCtD
Escitalopram—Diarrhoea—Gabapentin—epilepsy syndrome	4.89e-06	3.61e-05	CcSEcCtD
Escitalopram—Headache—Pregabalin—epilepsy syndrome	4.88e-06	3.6e-05	CcSEcCtD
Escitalopram—Urticaria—Topiramate—epilepsy syndrome	4.78e-06	3.53e-05	CcSEcCtD
Escitalopram—Body temperature increased—Topiramate—epilepsy syndrome	4.76e-06	3.51e-05	CcSEcCtD
Escitalopram—Abdominal pain—Topiramate—epilepsy syndrome	4.76e-06	3.51e-05	CcSEcCtD
Escitalopram—Dizziness—Gabapentin—epilepsy syndrome	4.73e-06	3.49e-05	CcSEcCtD
Escitalopram—Nausea—Pregabalin—epilepsy syndrome	4.63e-06	3.42e-05	CcSEcCtD
Escitalopram—Vomiting—Gabapentin—epilepsy syndrome	4.55e-06	3.35e-05	CcSEcCtD
Escitalopram—Rash—Gabapentin—epilepsy syndrome	4.51e-06	3.33e-05	CcSEcCtD
Escitalopram—Dermatitis—Gabapentin—epilepsy syndrome	4.5e-06	3.32e-05	CcSEcCtD
Escitalopram—Headache—Gabapentin—epilepsy syndrome	4.48e-06	3.31e-05	CcSEcCtD
Escitalopram—Hypersensitivity—Topiramate—epilepsy syndrome	4.43e-06	3.27e-05	CcSEcCtD
Escitalopram—Asthenia—Topiramate—epilepsy syndrome	4.32e-06	3.18e-05	CcSEcCtD
Escitalopram—Pruritus—Topiramate—epilepsy syndrome	4.26e-06	3.14e-05	CcSEcCtD
Escitalopram—Nausea—Gabapentin—epilepsy syndrome	4.25e-06	3.13e-05	CcSEcCtD
Escitalopram—Diarrhoea—Topiramate—epilepsy syndrome	4.12e-06	3.04e-05	CcSEcCtD
Escitalopram—Dizziness—Topiramate—epilepsy syndrome	3.98e-06	2.94e-05	CcSEcCtD
Escitalopram—Vomiting—Topiramate—epilepsy syndrome	3.82e-06	2.82e-05	CcSEcCtD
Escitalopram—Rash—Topiramate—epilepsy syndrome	3.79e-06	2.8e-05	CcSEcCtD
Escitalopram—Dermatitis—Topiramate—epilepsy syndrome	3.79e-06	2.8e-05	CcSEcCtD
Escitalopram—Headache—Topiramate—epilepsy syndrome	3.77e-06	2.78e-05	CcSEcCtD
Escitalopram—Nausea—Topiramate—epilepsy syndrome	3.57e-06	2.64e-05	CcSEcCtD
Escitalopram—ADRA1A—Signaling Pathways—CCR2—epilepsy syndrome	2.74e-06	6.36e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—NTRK2—epilepsy syndrome	2.74e-06	6.36e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—SST—epilepsy syndrome	2.74e-06	6.36e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—ADRA2A—epilepsy syndrome	2.73e-06	6.34e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	2.73e-06	6.33e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—ADRA2A—epilepsy syndrome	2.72e-06	6.32e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—PLAT—epilepsy syndrome	2.72e-06	6.31e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—DUSP6—epilepsy syndrome	2.72e-06	6.3e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—PLAT—epilepsy syndrome	2.71e-06	6.29e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—ADAM10—epilepsy syndrome	2.7e-06	6.27e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—CCL2—epilepsy syndrome	2.69e-06	6.24e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—ADRA2A—epilepsy syndrome	2.68e-06	6.22e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—PLAT—epilepsy syndrome	2.67e-06	6.2e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	2.66e-06	6.16e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—BDKRB2—epilepsy syndrome	2.62e-06	6.09e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CXCL12—epilepsy syndrome	2.62e-06	6.09e-05	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—POMC—epilepsy syndrome	2.62e-06	6.08e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—BDKRB2—epilepsy syndrome	2.62e-06	6.07e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CXCL12—epilepsy syndrome	2.62e-06	6.07e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—PRKCB—epilepsy syndrome	2.61e-06	6.06e-05	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—POMC—epilepsy syndrome	2.61e-06	6.06e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—PRKCB—epilepsy syndrome	2.6e-06	6.04e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—IL6ST—epilepsy syndrome	2.6e-06	6.04e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—IL6ST—epilepsy syndrome	2.59e-06	6.02e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—NT5E—epilepsy syndrome	2.59e-06	6.01e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ALAD—epilepsy syndrome	2.59e-06	6.01e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—JUNB—epilepsy syndrome	2.58e-06	5.98e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CNR1—epilepsy syndrome	2.58e-06	5.98e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—BDKRB2—epilepsy syndrome	2.58e-06	5.98e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CXCL12—epilepsy syndrome	2.58e-06	5.98e-05	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—POMC—epilepsy syndrome	2.57e-06	5.97e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—JUNB—epilepsy syndrome	2.57e-06	5.96e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CNR1—epilepsy syndrome	2.57e-06	5.96e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—PLCB1—epilepsy syndrome	2.57e-06	5.96e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—PRKCB—epilepsy syndrome	2.56e-06	5.95e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—PLCB1—epilepsy syndrome	2.56e-06	5.94e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—IL6ST—epilepsy syndrome	2.55e-06	5.93e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—S100B—epilepsy syndrome	2.55e-06	5.92e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	2.54e-06	5.89e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—JUNB—epilepsy syndrome	2.53e-06	5.87e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CNR1—epilepsy syndrome	2.53e-06	5.87e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—SOCS3—epilepsy syndrome	2.53e-06	5.87e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CDC42—epilepsy syndrome	2.52e-06	5.85e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—PLCB1—epilepsy syndrome	2.52e-06	5.85e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—HTR7—epilepsy syndrome	2.51e-06	5.83e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—HTR7—epilepsy syndrome	2.51e-06	5.81e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	2.47e-06	5.73e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	2.47e-06	5.73e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—HTR7—epilepsy syndrome	2.47e-06	5.72e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	2.46e-06	5.7e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—AVP—epilepsy syndrome	2.44e-06	5.67e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—HBEGF—epilepsy syndrome	2.44e-06	5.66e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.44e-06	5.66e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—HBEGF—epilepsy syndrome	2.43e-06	5.64e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	2.42e-06	5.61e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—AKT3—epilepsy syndrome	2.39e-06	5.56e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—HBEGF—epilepsy syndrome	2.39e-06	5.56e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—AKT3—epilepsy syndrome	2.39e-06	5.54e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—POMC—epilepsy syndrome	2.38e-06	5.52e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—POMC—epilepsy syndrome	2.37e-06	5.51e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ADSL—epilepsy syndrome	2.37e-06	5.49e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—AKT3—epilepsy syndrome	2.35e-06	5.45e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—ADAM10—epilepsy syndrome	2.34e-06	5.43e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—POMC—epilepsy syndrome	2.34e-06	5.42e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	2.33e-06	5.41e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—ADAM10—epilepsy syndrome	2.33e-06	5.41e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—CCL2—epilepsy syndrome	2.33e-06	5.4e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—CCL2—epilepsy syndrome	2.32e-06	5.39e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GLUL—epilepsy syndrome	2.32e-06	5.39e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—HES1—epilepsy syndrome	2.31e-06	5.36e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—ADAM10—epilepsy syndrome	2.3e-06	5.33e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—CCL2—epilepsy syndrome	2.28e-06	5.3e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	2.28e-06	5.29e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	2.27e-06	5.28e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	2.26e-06	5.24e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—FYN—epilepsy syndrome	2.24e-06	5.21e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—H2AFX—epilepsy syndrome	2.24e-06	5.19e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—MEF2C—epilepsy syndrome	2.23e-06	5.18e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.22e-06	5.16e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	2.22e-06	5.14e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—S100B—epilepsy syndrome	2.21e-06	5.13e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—S100B—epilepsy syndrome	2.2e-06	5.12e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—SOCS3—epilepsy syndrome	2.19e-06	5.08e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CDC42—epilepsy syndrome	2.19e-06	5.07e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—SOCS3—epilepsy syndrome	2.18e-06	5.07e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CDC42—epilepsy syndrome	2.18e-06	5.06e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—S100B—epilepsy syndrome	2.17e-06	5.04e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—YWHAZ—epilepsy syndrome	2.16e-06	5.01e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—SOCS3—epilepsy syndrome	2.15e-06	4.99e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CDC42—epilepsy syndrome	2.14e-06	4.98e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—NGF—epilepsy syndrome	2.13e-06	4.95e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	2.13e-06	4.95e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—AVP—epilepsy syndrome	2.12e-06	4.91e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	2.11e-06	4.9e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—AVP—epilepsy syndrome	2.11e-06	4.89e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—BCHE—epilepsy syndrome	2.1e-06	4.88e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—AVP—epilepsy syndrome	2.08e-06	4.82e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CCR5—epilepsy syndrome	2.08e-06	4.82e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—AQP1—epilepsy syndrome	2.07e-06	4.8e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—HTR2A—epilepsy syndrome	2.03e-06	4.71e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	2e-06	4.65e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—HES1—epilepsy syndrome	2e-06	4.64e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—HES1—epilepsy syndrome	1.99e-06	4.63e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	1.98e-06	4.6e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—TH—epilepsy syndrome	1.98e-06	4.59e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—HES1—epilepsy syndrome	1.96e-06	4.56e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—FYN—epilepsy syndrome	1.95e-06	4.51e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.95e-06	4.51e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	1.94e-06	4.5e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—FYN—epilepsy syndrome	1.94e-06	4.5e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—H2AFX—epilepsy syndrome	1.94e-06	4.5e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—MEF2C—epilepsy syndrome	1.93e-06	4.49e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—BCHE—epilepsy syndrome	1.93e-06	4.49e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—H2AFX—epilepsy syndrome	1.93e-06	4.48e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—TSC2—epilepsy syndrome	1.93e-06	4.48e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—MEF2C—epilepsy syndrome	1.93e-06	4.48e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—AGT—epilepsy syndrome	1.93e-06	4.47e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—FYN—epilepsy syndrome	1.91e-06	4.43e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—H2AFX—epilepsy syndrome	1.9e-06	4.41e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—MEF2C—epilepsy syndrome	1.9e-06	4.41e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—APOE—epilepsy syndrome	1.89e-06	4.38e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	1.87e-06	4.34e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	1.87e-06	4.34e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—YWHAZ—epilepsy syndrome	1.87e-06	4.34e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—YWHAZ—epilepsy syndrome	1.86e-06	4.33e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—KDR—epilepsy syndrome	1.85e-06	4.29e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—NGF—epilepsy syndrome	1.85e-06	4.29e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	1.84e-06	4.28e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—NGF—epilepsy syndrome	1.84e-06	4.28e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—YWHAZ—epilepsy syndrome	1.84e-06	4.26e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	1.82e-06	4.23e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—TH—epilepsy syndrome	1.82e-06	4.22e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—NGF—epilepsy syndrome	1.81e-06	4.21e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CCR5—epilepsy syndrome	1.8e-06	4.17e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CCR5—epilepsy syndrome	1.79e-06	4.16e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—PRKCB—epilepsy syndrome	1.78e-06	4.13e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—IL6ST—epilepsy syndrome	1.77e-06	4.12e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CCR5—epilepsy syndrome	1.77e-06	4.1e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—HTR2A—epilepsy syndrome	1.76e-06	4.09e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—HTR2A—epilepsy syndrome	1.75e-06	4.07e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—HTR2A—epilepsy syndrome	1.73e-06	4.01e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—TSC2—epilepsy syndrome	1.67e-06	3.88e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—AGT—epilepsy syndrome	1.67e-06	3.88e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—TSC2—epilepsy syndrome	1.67e-06	3.87e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—AGT—epilepsy syndrome	1.66e-06	3.86e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	1.65e-06	3.83e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—TSC2—epilepsy syndrome	1.64e-06	3.81e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—AGT—epilepsy syndrome	1.64e-06	3.8e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—APOE—epilepsy syndrome	1.64e-06	3.8e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—APOE—epilepsy syndrome	1.63e-06	3.79e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CAT—epilepsy syndrome	1.63e-06	3.78e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—POMC—epilepsy syndrome	1.62e-06	3.77e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—APOE—epilepsy syndrome	1.61e-06	3.73e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—KDR—epilepsy syndrome	1.6e-06	3.72e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—KDR—epilepsy syndrome	1.6e-06	3.71e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CCL2—epilepsy syndrome	1.59e-06	3.68e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	1.58e-06	3.67e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—KDR—epilepsy syndrome	1.57e-06	3.65e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—PRKCB—epilepsy syndrome	1.54e-06	3.58e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—PRKCB—epilepsy syndrome	1.54e-06	3.57e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—IL6ST—epilepsy syndrome	1.54e-06	3.57e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—IL6ST—epilepsy syndrome	1.53e-06	3.56e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.53e-06	3.54e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	1.52e-06	3.52e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—PRKCB—epilepsy syndrome	1.51e-06	3.51e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—IL6ST—epilepsy syndrome	1.51e-06	3.5e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CAT—epilepsy syndrome	1.5e-06	3.47e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.49e-06	3.45e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.48e-06	3.43e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—GPX1—epilepsy syndrome	1.47e-06	3.41e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	1.46e-06	3.38e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—FGF2—epilepsy syndrome	1.43e-06	3.33e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—POMC—epilepsy syndrome	1.41e-06	3.26e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—POMC—epilepsy syndrome	1.4e-06	3.25e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—POMC—epilepsy syndrome	1.38e-06	3.2e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CCL2—epilepsy syndrome	1.38e-06	3.19e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CCL2—epilepsy syndrome	1.37e-06	3.18e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GPX1—epilepsy syndrome	1.35e-06	3.14e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CCL2—epilepsy syndrome	1.35e-06	3.13e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.33e-06	3.09e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—RELA—epilepsy syndrome	1.33e-06	3.09e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—MTOR—epilepsy syndrome	1.31e-06	3.03e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—AGT—epilepsy syndrome	1.29e-06	2.99e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.27e-06	2.95e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—APOE—epilepsy syndrome	1.26e-06	2.93e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.26e-06	2.93e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—FGF2—epilepsy syndrome	1.24e-06	2.89e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—FGF2—epilepsy syndrome	1.24e-06	2.88e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—FGF2—epilepsy syndrome	1.22e-06	2.83e-05	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—AKT1—epilepsy syndrome	1.21e-06	2.81e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.21e-06	2.8e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CASP3—epilepsy syndrome	1.2e-06	2.79e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.19e-06	2.77e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—TH—epilepsy syndrome	1.19e-06	2.76e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—AGT—epilepsy syndrome	1.19e-06	2.75e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—JUN—epilepsy syndrome	1.17e-06	2.71e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—APOE—epilepsy syndrome	1.16e-06	2.7e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—RELA—epilepsy syndrome	1.15e-06	2.68e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—RELA—epilepsy syndrome	1.15e-06	2.67e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—MMP9—epilepsy syndrome	1.14e-06	2.63e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—RELA—epilepsy syndrome	1.13e-06	2.63e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—MTOR—epilepsy syndrome	1.13e-06	2.63e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—MTOR—epilepsy syndrome	1.13e-06	2.62e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—MTOR—epilepsy syndrome	1.11e-06	2.58e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—AKT1—epilepsy syndrome	1.1e-06	2.56e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—POMC—epilepsy syndrome	1.09e-06	2.52e-05	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—AKT1—epilepsy syndrome	1.05e-06	2.44e-05	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	1.05e-06	2.43e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—SRC—epilepsy syndrome	1.05e-06	2.43e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CASP3—epilepsy syndrome	1.04e-06	2.42e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CASP3—epilepsy syndrome	1.04e-06	2.41e-05	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—AKT1—epilepsy syndrome	1.03e-06	2.39e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CASP3—epilepsy syndrome	1.02e-06	2.37e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—VEGFA—epilepsy syndrome	1.02e-06	2.37e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—JUN—epilepsy syndrome	1.01e-06	2.35e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—JUN—epilepsy syndrome	1.01e-06	2.34e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—POMC—epilepsy syndrome	9.99e-07	2.32e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—JUN—epilepsy syndrome	9.92e-07	2.3e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	9.92e-07	2.3e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—ALB—epilepsy syndrome	9.9e-07	2.3e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—MMP9—epilepsy syndrome	9.84e-07	2.28e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—MMP9—epilepsy syndrome	9.8e-07	2.28e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CAT—epilepsy syndrome	9.78e-07	2.27e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—MMP9—epilepsy syndrome	9.65e-07	2.24e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—AKT1—epilepsy syndrome	9.54e-07	2.21e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	9.52e-07	2.21e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—AKT1—epilepsy syndrome	9.51e-07	2.21e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—AKT1—epilepsy syndrome	9.36e-07	2.17e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—ALB—epilepsy syndrome	9.11e-07	2.11e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—SRC—epilepsy syndrome	9.07e-07	2.1e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—SRC—epilepsy syndrome	9.04e-07	2.1e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—SRC—epilepsy syndrome	8.9e-07	2.07e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GPX1—epilepsy syndrome	8.85e-07	2.05e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—VEGFA—epilepsy syndrome	8.83e-07	2.05e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—VEGFA—epilepsy syndrome	8.8e-07	2.04e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—VEGFA—epilepsy syndrome	8.67e-07	2.01e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	8.66e-07	2.01e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	7.97e-07	1.85e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—AGT—epilepsy syndrome	7.76e-07	1.8e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—APOE—epilepsy syndrome	7.6e-07	1.76e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—POMC—epilepsy syndrome	6.53e-07	1.52e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—AKT1—epilepsy syndrome	6.5e-07	1.51e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ALB—epilepsy syndrome	5.95e-07	1.38e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—AKT1—epilepsy syndrome	5.64e-07	1.31e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—AKT1—epilepsy syndrome	5.62e-07	1.3e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—AKT1—epilepsy syndrome	5.53e-07	1.28e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	5.21e-07	1.21e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—AKT1—epilepsy syndrome	4.35e-07	1.01e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—AKT1—epilepsy syndrome	4e-07	9.29e-06	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—AKT1—epilepsy syndrome	2.62e-07	6.08e-06	CbGpPWpGaD
